<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03041428</url>
  </required_header>
  <id_info>
    <org_study_id>FINBA_CritLab_1</org_study_id>
    <nct_id>NCT03041428</nct_id>
  </id_info>
  <brief_title>Ultra Protective Ventilation During Venoarterial Extracorporeal Membrane Oxygenation (UPV-ECMO)</brief_title>
  <acronym>UPV-ECMO</acronym>
  <official_title>Effect of Ultraprotective Ventilation on the Lung Inflammatory Response in Patients With Acute Pulmonary Edema Treated With Venoarterial Extracorporeal Oxygenation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación para la Investigación Biosanitaria del Principado de Asturias</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación para la Investigación Biosanitaria del Principado de Asturias</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mechanical ventilation, in spite of being a life-saving technique, can also induce lung
      injury (VILI) mediated by an inflammatory response, thus having a profound impact in the
      course of critically ill patients. Ventilatory strategies aimed to minimize this VILI have
      reduced mortality rates. Patients suffering cardiogenic pulmonary edema may need venoarterial
      extracorporeal oxygenation, at the same time they are being mechanically ventilated. The
      objective of this study is to analyze changes induced by the use of utraprotective
      ventilatory strategies in the inflammatory lung response of these patients and their impact
      on outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mechanical ventilation is the cornerstone of the critically-ill patients support, providing
      better gas exchange conditions while respiratory muscles rest. Providing this life-support
      technique may be harmful on the lung tissue, last decades research efforts were focused on
      minimizing the ventilator-induced lung injury (VILI). Knowledge regarding the mechanisms of
      this injury has led to changes in the clinical practice, consisting on the application of
      positive end-expiratory pressure (PEEP) and the use of low tidal volumes, giving rise to the
      strategy known as &quot;protective ventilation&quot;. Moreover, the use of extracorporeal membrane
      oxygenation (ECMO) techniques contributes to maintaining an adequate gas exchange until lung
      damage resolution. A tidal volume in the range of 6 ml/Kg of ideal body weight, with a
      reasonable level of PEEP is the standard of care for patients with the ARDS. However, optimal
      levels of tidal volume and PEEP have not been completely established. On the other side,
      decreasing tidal volume below 6 ml/Kg faces its own problems. The role of the so-called
      &quot;ultraprotective&quot; approaches, in which extracorporeal support is required to reduce tidal
      volumes up to 3 ml/kg or less, although feasible, is currently under research. During
      venoarterial ECMO, blood is removed from the vessels and pumped through a circuit where is
      oxygenated and CO2 is removed; finally, the blood is returned to the arterial circulation.
      The development of new circuits and devices made this therapy become safer and more useful,
      improving outcomes so that its application has been widespread to many centers all over the
      world. One of the ECMO advantages is carbon dioxide removal, which allows reducing tidal
      volume below 6 ml/kg. Ultraprotective strategies with 3 ml/kg have demonstrated to be
      feasible, but the additional benefit of this strategy is to be demonstrated. Therefore, in
      this study, patients suffering cardiogenic pulmonary edema requiring ECMO and mechanical
      ventilation are submitted to an ultraprotective ventilator strategy. Lung inflammatory
      response is measured before and after the intervention, in order to evaluate its impact in
      this subset of patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">March 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in lung inflammatory mediators levels</measure>
    <time_frame>Baseline and 18 hours after the intervention</time_frame>
    <description>Bronchoalveolar lavage cytokines levels, measured in ng/ml</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Cardiogenic Pulmonary Edema</condition>
  <condition>Ventilator-Induced Lung Injury</condition>
  <condition>Extracorporeal Circulation; Complications</condition>
  <arm_group>
    <arm_group_label>Recruited patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultraprotective ventilation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultraprotective ventilation</intervention_name>
    <description>Adjusting ventilator parameters for 3 ml/kg of tidal volume in order to achieve the ultra protective strategy</description>
    <arm_group_label>Recruited patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cardiogenic pulmonary edema supported by venoarterial extracorporeal membrane
             oxygenation.

          -  Invasive mechanical ventilatory support under sedation.

        Exclusion Criteria:

          -  Immunosupresion.

          -  Hemodynamic instability refractory to mechanical support, conditioning an end-of-life
             approach and terminal situation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillermo M Albaiceta</last_name>
    <role>Principal Investigator</role>
    <affiliation>HUCA-FINBA, Universidad de Oviedo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guillermo M Albaiceta, MD, PhD</last_name>
    <phone>+34 985652433</phone>
    <email>lab.catorce@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario Central de Asturias (HUCA)</name>
      <address>
        <city>Oviedo</city>
        <state>Principado De Asturias</state>
        <zip>33011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillermo M Albaiceta, MD, PhD</last_name>
      <phone>+34 985652433</phone>
      <email>lab.catorce@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Laura Amado-Rodríguez, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cecilia del Busto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8.</citation>
    <PMID>10793162</PMID>
  </reference>
  <reference>
    <citation>Leligdowicz A, Fan E. Extracorporeal life support for severe acute respiratory distress syndrome. Curr Opin Crit Care. 2015 Feb;21(1):13-9. doi: 10.1097/MCC.0000000000000170. Review.</citation>
    <PMID>25517890</PMID>
  </reference>
  <reference>
    <citation>Determann RM, Royakkers A, Wolthuis EK, Vlaar AP, Choi G, Paulus F, Hofstra JJ, de Graaff MJ, Korevaar JC, Schultz MJ. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Crit Care. 2010;14(1):R1. doi: 10.1186/cc8230. Epub 2010 Jan 7.</citation>
    <PMID>20055989</PMID>
  </reference>
  <reference>
    <citation>Terragni PP, Rosboch G, Tealdi A, Corno E, Menaldo E, Davini O, Gandini G, Herrmann P, Mascia L, Quintel M, Slutsky AS, Gattinoni L, Ranieri VM. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2007 Jan 15;175(2):160-6. Epub 2006 Oct 12.</citation>
    <PMID>17038660</PMID>
  </reference>
  <reference>
    <citation>Figueroa-Casas JB, Montoya R. Effect of Tidal Volume Size and Its Delivery Mode on Patient-Ventilator Dyssynchrony. Ann Am Thorac Soc. 2016 Dec;13(12):2207-2214.</citation>
    <PMID>27598383</PMID>
  </reference>
  <reference>
    <citation>Bein T, Weber-Carstens S, Goldmann A, Müller T, Staudinger T, Brederlau J, Muellenbach R, Dembinski R, Graf BM, Wewalka M, Philipp A, Wernecke KD, Lubnow M, Slutsky AS. Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study. Intensive Care Med. 2013 May;39(5):847-56. doi: 10.1007/s00134-012-2787-6. Epub 2013 Jan 10.</citation>
    <PMID>23306584</PMID>
  </reference>
  <reference>
    <citation>Fan E, Gattinoni L, Combes A, Schmidt M, Peek G, Brodie D, Muller T, Morelli A, Ranieri VM, Pesenti A, Brochard L, Hodgson C, Van Kiersbilck C, Roch A, Quintel M, Papazian L. Venovenous extracorporeal membrane oxygenation for acute respiratory failure : A clinical review from an international group of experts. Intensive Care Med. 2016 May;42(5):712-724. doi: 10.1007/s00134-016-4314-7. Epub 2016 Mar 23. Review.</citation>
    <PMID>27007108</PMID>
  </reference>
  <reference>
    <citation>Schmidt M, Stewart C, Bailey M, Nieszkowska A, Kelly J, Murphy L, Pilcher D, Cooper DJ, Scheinkestel C, Pellegrino V, Forrest P, Combes A, Hodgson C. Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome: a retrospective international multicenter study. Crit Care Med. 2015 Mar;43(3):654-64. doi: 10.1097/CCM.0000000000000753.</citation>
    <PMID>25565460</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2017</study_first_submitted>
  <study_first_submitted_qc>February 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2017</study_first_posted>
  <last_update_submitted>February 9, 2018</last_update_submitted>
  <last_update_submitted_qc>February 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Injury</mesh_term>
    <mesh_term>Pulmonary Edema</mesh_term>
    <mesh_term>Ventilator-Induced Lung Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

